Several members of Emcure Pharmaceuticals’ promoter group have withdrawn their application seeking re-classification of their shareholding to the ‘Public’ category. A total of 15 members, initially part of the re-classification request, have decided to remain within the Promoter and Promoter Group, as confirmed by their letter dated October 7, 2025. The company has already submitted an application for the withdrawal of the said re-classification.
Re-classification Plans Halted
Emcure Pharmaceuticals has announced that certain members of its Promoter and Promoter Group have decided to withdraw their application for re-classification of their shareholding. This development comes after the initial requests were made public in June.
Key Details of the Withdrawal
The decision to withdraw the re-classification application involves a total of 15 members of the Promoter and Promoter Group. These members have formally communicated their intent to remain as part of the Promoter and Promoter Group of the company via a letter dated October 7, 2025.
Entities Retaining Promoter Status
The following entities will remain classified under the “Promoter” category:
- Uth Beverage Factory Private Limited
- Thapar Ventures Private Limited
- Avet Lifesciences Private Limited
- Thapar Vision LLP
- Heritage Pharma Holdings Inc.
- H. M. Sales Corporation
- Sassy Stories
- Indus Trust
- Tulsi Trust
- Cayuga Trust
- Menlo Trust
- Sapphire Trust
- Himalayan Trust
- Incredible Ideas Private Limited
- Incredible Ventures Private Limited
Source: BSE
